# The Efficacy of Oral Probiotics on Neonatal Hyperbilirubinemia

> **NCT03876678** · NA · UNKNOWN · sponsor: **China Medical University Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Hyperbilirubinemia, Neonatal

## Interventions

- **OTHER:** Lactobacillus salivarius AP-32
- **OTHER:** Bifidobacterium animalis subspecies lactis CP-9
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03876678
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-24
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2023-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03876678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03876678, "The Efficacy of Oral Probiotics on Neonatal Hyperbilirubinemia". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT03876678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*